REDEEMABLE CONVERTIBLE PREFERRED STOCK ESCROWED PROCEEDS AND STOCKHOLDERS EQUITY (Details Narrative) - USD ($)		1 Months Ended				3 Months Ended			6 Months Ended	9 Months Ended		12 Months Ended
	May 11, 2022	Feb. 29, 2024	Oct. 20, 2023	Dec. 16, 2022	Oct. 31, 2022	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2022	Mar. 31, 2024	Mar. 31, 2023	Jun. 30, 2023	Jun. 30, 2022	Jan. 31, 2024	Jun. 30, 2021	Jun. 30, 2020
Stock based compensation, options						$ 205,176		$ 121,584	$ 382,541	$ 615,716
Number of common stock share					798,182					1,033,491		1,033,491
Exercise price per share			$ 2.12		$ 5.83									$ 5.46
Fees and expenses			$ 4,573,948		$ 9,109,117					$ 9,224,056
Gross proceeds										$ 10,000,006,000,000
Voting of shares description										The holders of Series C Preferred Stock were entitled to 20,000 votes per share
Exercise price			$ 0.0001		$ 0.0001	$ 6.82				$ 6.82
Description of commission										The Company pays Canaccord 3.0% of the gross proceeds as a commission
Unvested performance-based restricted stock												$ 238,838	$ 60,566		$ 95,167	$ 87,303
Unvested performance-based stock options granted to executive officers and other employees						318,813				318,813
Unvested performance-based stock options granted						57,999				57,999
Stock based compensation, restricted stock units						$ 185,019	$ 202,512			$ 555,057	$ 612,132
Outstanding vested restricted stock unit						279,700				279,700
Description of securities purchase agreement		the Company issued to the investors in the January 2024 RD Offering unregistered warrants (the “January 2024 Private Warrants”) to purchase up to 1,831,503 shares of the Company’s common stock (the “January 2024 Private Warrant Shares”) in a concurrent private placement (the “Private Offering” and together with the January 2024 RD Offering, the “January 2024 Offering”). The shares of common stock and accompanying January 2024 Private Warrants were offered at a combined offering price of $5.46	(i) 1,325,000 shares of common stock (the “October 2023 Shares”), of the Company and (ii) pre-funded warrants (the “October 2023 Pre-Funded Warrants”) to purchase up to 1,033,491 shares of the Company’s common stock (the “October 2023 Pre-Funded Warrant Shares”). Pursuant to the October 2023 Purchase Agreement the Company also issued unregistered warrants (the “October 2023 Private Warrants”) to purchase up to 2,358,491 shares of the Company’s common stock (the “October 2023 Private Warrant Shares”) in a concurrent private placement (the “October 2023 Private Offering” and together with the October 2023 RD Offering, the “October 2023 Offering”). The October 2023 Shares and accompanying October 2023 Private Warrants were offered at a combined offering price of $2.12. The October 2023 Pre-Funded Warrants and accompanying October 2023 Private Warrants were offered at a combined offering price of $2.1199		(i) 1,020,000 shares of the Company’s common stock, (ii) prefunded warrants (the “October 2022 Pre-Funded Warrants”) to purchase up to 798,182 shares of the Company’s common stock, and (iii) common stock warrants (the “October 2022 Common Warrants”) to purchase up to 1,818,182 shares of the Company’s common stock. Each share of common stock was offered with one accompanying October 2022 Common Warrant with a combined offering price of $5.50. Each October 2022 Pre-Funded Warrant was offered with one accompanying October 2022 Common Warrant with a combined offering price of $5.4999
Total gross proceeds										$ 15,000,000
Account to release										171,000,000
Distributable value of dividend						$ 100				100
Selling, general and administrative expenses						$ 2,033,410	$ 3,537,376			$ 8,266,267	$ 10,220,518
Executive Officers
Unvested performance-based stock options granted to executive officers and other employees						217,833				217,833
Unvested performance-based stock options granted						37,116				37,116
Unvested performance-based restricted stock units granted												152,432	40,707		22,343	52,679
Convertible Series A Preferred Stocks
Convertible preferred stock were outstanding						4,030				4,030
Aggregate value										$ 403,000
Conversion price						$ 75.45				$ 75.45
Convertible shares						$ 1.33				$ 1.33
Distributable value of dividend						$ 100				$ 100
Distributable value of dividend additional						$ 100				100
Series B Convertible Preferred Stock
Fee										750,000
Selling, general and administrative expenses													$ 150,995
Fair value of the warrants													$ (234,443)
Securities Purchase Agreement Plan [Member] | Series B and C Redeemable Convertible Preferred Stock [Member]
Exercise price	$ 12.50
Account to release										15,750,000
Fee										750,000
Warrants to purchase up	66,666
Total gross proceeds from the offering										$ 15,000,000
Expiry of share issuance	48 years
Securities Purchase Agreement [Member] | Series B Redeemable Convertible Preferred Stock [Member]
Shares sold	8,100,000
Securities Purchase Agreement [Member] | Series C Redeemable Convertible Preferred Stock [Member]
Shares sold	900,000
Share purchase price	$ 1.67
2011 Stock Incentive Plan [Member] | President and CEO [Member]
Voluntarily contributed stock options number of share				143,360
2011 Stock Incentive Plan [Member] | CFO and COO [Member]
Voluntarily contributed stock options number of share				124,220
2023 Equity Distribution Agreement [Member]
Description of equity distribution agreement										The 2023 Equity Distribution Agreement and related prospectus is limited to sales of up to an aggregate maximum $50.0 million of shares of the Company’s common stock
Vesting of restricted share units										25,467
Vesting of restricted share units value aggregate										$ 56,401